Latest AI and machine learning research in other cancers for healthcare professionals.
PURPOSE: Accurate prediction of lymph node metastasis (LNM) remains challenging in early gastric cancer (EGC), particularly when determining the need for additional surgery after endoscopic resection. We developed and evaluated a deep learning framework using multiple pathology foundation models for LNM prediction and explored histological features associated with model-predicted metastatic risk. ...
Lineage plasticity has emerged as a central mechanism through which cancer cells adapt to therapeutic pressure, evade immune surveillance, and acquire aggressive phenotypes. Although recognized across tumor types, the regulatory principles governing how cancer cells reprogram cellular identity remain incompletely understood. In this review, we propose that lineage plasticity in cancer reflects the...
RATIONALE AND OBJECTIVES: To address the challenge of preoperative prediction of synchronous liver metastasis (LM) in pancreatic cancer (PC), we devel...
To develop and internally validate a multimodal ultrasound-based decision support framework for benign-malignant risk stratification of Bethesda IV th...
INTRODUCTION: We examined whether machine learning identified baseline variables that predicted two-year prevention and remission from anxiety, depres...
Paclitaxel (PTX) chemotherapy is constrained by an "immunomodulatory paradox," where antitumor Type I Interferon (IFN-I) activation is coupled with de...
Multimodal artificial intelligence (AI) is reshaping prostate cancer imaging by moving beyond MRI-only algorithms toward models that integrate multipa...
Breast cancer continues to be a leading cause of cancer-related mortality in women globally, where precise diagnosis and clear tumor demarcation are c...
Response assessment of primary kidney tumors in the consolidation cytoreductive and neoadjuvant settings offers a unique opportunity to inform postope...
Cancer vaccines are emerging as a promising approach in immuno-oncology, with the potential to generate tumour-specific and long-lasting immune respon...
OBJECTIVE: To develop and externally validate an integrated model that combines multimodality CT-MRI deep learning with clinical and radiological feat...
Esophageal squamous cell carcinoma (ESCC) is characterized by substantial intratumoral heterogeneity and poor clinical prognosis. Although metalloprot...
Cervical cancer is a leading preventable cause of cancer morbidity and mortality globally. Previous studies have indicated that dysregulation of the u...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignant cancer with limited biomarkers for early detection and disease stratification. He...
OBJECTIVES: Cervical cancer is a leading female malignancy with high global morbidity/mortality, and remains high recurrence risk after standard treat...
INTRODUCTION: Posttranslational modification (PTM) plays an important role in protein regulation and may influence tumor initiation and progression. H...
Deep learning models are increasingly used to analyze medical images, but their "black box" nature makes it hard to understand the underlying biology ...
Programmed death-ligand 1 (PD-L1) expression, commonly quantified as tumour proportion score (TPS), is a key biomarker guiding immunotherapy in non-sm...
BACKGROUND: Actinic cheilitis (AC) is a potentially malignant oral disorder linked to lip squamous cell carcinoma (LSCC). Clinical diagnosis is hinder...
Neoantigens are tumor-specific antigens resulting from genetic, transcriptomic, and proteomic changes, making them a promising avenue for personalized...